Fig. 3From: Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapya ROC curve showing the cutoff values of predictors of complications in DAAs-treated patients. b ROC curve showing the cutoff values of predictors of complications in sorafenib-treated patientsBack to article page